tDCS and cognitive training as a neurodevelopmental intervention in FASD
tDCS and cognitive training as a neurodevelopmental intervention in FASD
批准号:
10680393
负责人:
JEFFREY ROBERT WOZNIAK
金额:
$44.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-10 至 2027-04-30
关键词:
AdolescentAgeAttentionAttention deficit hyperactivity disorderBehaviorBehavioralBrainChildClientClinicalClinical TrialsCognitionCognitive deficitsCraniofacial AbnormalitiesDataDevelopmentDoseFetal Alcohol ExposureFetal Alcohol Spectrum DisorderFetal alcohol effectsFunctional Magnetic Resonance ImagingFutureGenetic Complementation TestGrowthHourImpaired cognitionImpairmentIndependent LivingIndividualInterventionIntervention StudiesInvestmentsLearningLeftLifeLinkMeasuresMediatingMental HealthMethodologyNeurocognitiveNeurologicNeuronal PlasticityOutcomeOutcome MeasureParentsParticipantPerformancePilot ProjectsPlacebosPopulationPrefrontal CortexPublic HealthPublishingRandomized, Controlled TrialsRegimenReportingResearchRestShort-Term MemorySocial FunctioningSymptomsTestingTherapeuticTimeTrainingarmattentional controlbehavioral impairmentclinical implementationcognitive controlcognitive functioncognitive performancecognitive trainingcomparison interventioncomputerizeddesigndosageemotional functioningexecutive functionimprovedneuralneuroregulationperformance testspost interventionresponsesafety and feasibilitysocial skillssustained attentiontranscranial direct current stimulationtreatment effectvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Fetal alcohol spectrum disorders (FASDs) comprise a range of effects from prenatal alcohol exposure
(PAE) including neurological abnormalities, cognitive and behavioral impairments, growth retardation,
and craniofacial anomalies. Very few treatments have been investigated despite the tremendous
public health burden posed by FASD. Cognition is a natural target for intervention because deficits
contribute to problems with adaptive functioning, social skills, and independent living. A decade of
research suggests that cognitive training has beneficial effects on functional brain networks -
mediating cognition in a variety of neurodevelopmental and mental health conditions. We believe it
can improve cognitive performance in individuals with FASD. The primary objective of our existing
line of neuromodulation research and the proposed RCT is to leverage the ability of tDCS to enhance
cortical excitability and neural plasticity in order to maximize the cognitive training benefits in children
and adolescents with FASD.
Recently we carried out a pilot randomized controlled trial of tDCS-augmented cognitive
training to demonstrate the safety and feasibility of this approach in children with FASD (Boroda,
Krueger, et al., 2020). We showed that the intervention was safe and well-tolerated in this population.
Further, despite applying a relatively low-dose of tDCS and cognitive training, we found that the group
receiving active-tDCS demonstrated greater improvements on an attention task than a group
receiving sham-tDCS. These promising pilot results merit replication in a larger clinical trial.
We propose a fully-powered randomized controlled trial of 60 (at completion) children and
adolescents with FASD who will receive cognitive training in combination with tDCS. We hypothesize
that, in conjunction with cognitive training, five initial sessions of active tDCS will produce a
significantly greater improvement in sustained attention (CPT) than sham tDCS. We also
hypothesize that, in conjunction with cognitive training, a total of ten sessions of active tDCS will
produce a significantly greater improvement in sustained attention (CPT) than five sessions of active
tDCS. We also aim to establish the long-term durability of neurocognitive improvements and
associated behavioral changes resulting from tDCS and cognitive training. Finally, we plan to use
pre-intervention and post-intervention resting-state fMRI data to show functional network changes
related to the intervention and to quantify the relationship between dose and functional network
changes. Results of the trial will directly inform future clinical implementation of cognitive training and
tDCS as a potential neurodevelopmental intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
tDCS and cognitive training as a neurodevelopmental intervention in FASD
-
批准号:10467243
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2022
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
Postnatal Choline Supplementation in Children with Prenatal Alcohol Exposure
-
批准号:8319696
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2009
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
Postnatal Choline Supplementation in Children with Prenatal Alcohol Exposure
-
批准号:8332275
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2009
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
Postnatal Choline Supplementation in Children with Prenatal Alcohol Exposure
-
批准号:8530112
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2009
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
Postnatal Choline Supplementation in Children with Prenatal Alcohol Exposure
-
批准号:7942035
-
项目类别:
-
资助金额:$20.18万
-
财政年份:2009
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
SENSITIVITY OF DIFFUSION TENSOR IMAGING (DTI) IN MILD TO MODERATEL PEDIATRIC TRA
-
批准号:7951688
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2008
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
NEURODEVELOPMENTAL EFFECTS OF FETAL ALCOHOL EXPOSURE
-
批准号:7951660
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2008
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
SENSITIVITY OF DIFFUSION TENSOR IMAGING (DTI) IN MILD TO MODERATEL PEDIATRIC TRA
-
批准号:7606061
-
项目类别:
-
资助金额:$1.08万
-
财政年份:2006
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
NEURODEVELOPMENTAL EFFECTS OF FETAL ALCOHOL EXPOSURE
-
批准号:7606003
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2006
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
NEURODEVELOPMENTAL EFFECTS OF FETAL ALCOHOL EXPOSURE
-
批准号:7375933
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2005
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
NEURODEVELOPMENTAL EFFECTS OF FETAL ALCOHOL EXPOSURE
-
批准号:7206526
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2005
-
负责人:JEFFREY ROBERT WOZNIAK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: